14,590
Total Claims
$3.2M
Drug Cost
1,559
Beneficiaries
$2,026
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+33%
Cost per patient vs peers
$2,026 vs $1,524 avg
+16%
Brand preference vs peers
15.9% vs 13.7% avg
Opioid Prescribing
0.4%
Opioid Rate
53
Opioid Claims
$1,183
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
84% generic
Brand: 2,314 claims · $2.9M
Generic: 12,276 claims · $290K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rivaroxaban | 627 | $843K |
| Apixaban | 564 | $737K |
| Sacubitril/Valsartan | 404 | $635K |
| Dronedarone Hcl | 76 | $154K |
| Dapagliflozin Propanediol | 103 | $142K |
| Evolocumab | 189 | $119K |
| Empagliflozin | 75 | $115K |
| Alirocumab | 64 | $43K |
| Rosuvastatin Calcium | 1,241 | $33K |
| Ezetimibe | 739 | $31K |
| Metoprolol Succinate | 1,014 | $24K |
| Atorvastatin Calcium | 1,376 | $24K |
| Valsartan | 527 | $20K |
| Ticagrelor | 25 | $19K |
| Diltiazem Hcl | 286 | $17K |
Prescribing Profile
62
Unique Drugs
$2.5M
Patient Profile
75
Avg Age
48%
Female
1.41
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data